CE Mark for Advanced Cooling Therapy’s Novel Esophageal Cooling Device

An emerging medical device manufacturing company (that we’d never come across until now), Advanced Cooling Therapy (ACT), has received CE marking for its first product, the Esophageal Cooling Device (ECD) to control patient temperature. The product is now available to medical professionals in Europe.

Background

Advanced Cooling Therapy says its novel technology platform provides improved methods to control patient temperature where clinically indicated using the esophageal environment.

The ECD is a single use, fully-enclosed triple lumen system that is inserted into the esophagus. Used to modulate and control patient temperature when clinically indicated, the system facilitates passage of appropriate temperature water, directly into the Esophagus. Two lumens attach to existing temperature modulation equipment while a third lumen simultaneously allows gastric decompression and drainage. The ECD can be rapidly inserted by most trained health care professionals, in similar fashion to a standard gastric tube, and can be used to control patient temperature in the operating room, recovery room, emergency room, or ICU. No other product on the market is approved to use the esophageal environment for whole-body temperature modulation.

Company comments

ACT’s President and Co-Founder, Erik Kulstad, MD, MS, said, “As an Emergency Room physician, I know intimately the challenges associated with traditional temperature management – bulky blankets, expensive machines, and invasive catheter procedures. The ECD is safe, easy to use, and cost-effective, and we look forward to commercialization in Europe with the CE marking.”

Source: Advanced Cooling Therapy, LLC., Business Wire

Share your thoughts

Your email address will not be published. Required fields are marked *